期刊文献+

乳酸、降钙素原、N-端脑利钠肽及D-二聚体对脓毒症预后的分析 被引量:2

Prognostic Significance of Serum Lactic Acid, Procalcitonin,D-Dimer, N-terminal Pro-B-type Natriuretic Peptide in Patients With Sepsis
下载PDF
导出
摘要 目的比较血清乳酸、降钙素原、N-端脑利钠肽、D-二聚体及急性生理学与慢性健康评分Ⅱ对脓毒症患者预后的预测价值。方法收集2012年1月—2017年1月长春中医药大学附属医院急诊ICU科收治的符合脓毒症诊断标准患者62例,记录生命体征及各项检查指标,总结APACHE-Ⅱ评分,根据其预后分为生存组与死亡组,对相关数据进行统计学分析。结果 4种标记物及APACHE-Ⅱ评分在两组患者中均有显著差异,对死亡的预测有较高的敏感性与特异性,ROC曲线下面积为0.726~0.781之间。结论血清乳酸、降钙素原、N-端脑利钠肽及D-二聚体对脓毒症患者的死亡有预测价值,联合监测可提高预测的敏感性。 Objective To investigate the prognostic significance of serum lactic acid, procalcitonin, D-Dimer, N-terminal pro-B-type natriuretic peptide and APACHE- Ⅱ scores in patients with sepsis. Methods 62 septic patients from the affiliated hospital of Changchun Traditional Chinese Medicine University between January 2012 to January 2017 who met sepsis defnition criteria were divided into survival group and non-survival group according to their outcome. Vital signs and laboratory dates were recorded, APACHE-Ⅱ were scored. The results were analyzed statistically. Results There were signifcant differences in levels of 4 biomarkers and APACHE-Ⅱ score between 2 groups. For biomarkers had area under the curve (AUC) around 0.726~0.781. Conclusion Serum lactic acid, procalcitonin, D-Dimer and N-terminal pro-B-type natriuretic peptide are all good biomarkers for estimating patients prognosis and combined estimation can increase the sensitivity.
出处 《中国卫生标准管理》 2017年第28期127-129,共3页 China Health Standard Management
基金 国家级大学生创新创业训练计划(项目编号201610199039)
关键词 脓毒症 乳酸 降钙素原 N-端脑利钠肽 D-二聚体 APACHE-Ⅱ评分 sepsis serum lactic acid procalcitonin N-terminal pro-B-type natriuretic peptide D-Dimer APACHE-Ⅱ
  • 相关文献

参考文献4

二级参考文献48

  • 1明自强,俞林明,吕银祥,王黎卫,吕少敏.生脉注射液和复方丹参注射液治疗急性脓毒性心肌病疗效观察[J].中国中西医结合急救杂志,2006,13(6):364-366. 被引量:11
  • 2姚咏明.免疫功能紊乱在脓毒症发病中的作用及意义[J].中国危重病急救医学,2007,19(3):138-141. 被引量:63
  • 3Clae ys R,Vinken S,Spapen H.Plasma procalcitonin and C-reactive protein in a cute septic shock:clinical and biological correlate[J].Crit Care Med,2002,30( 4):757-762.
  • 4Wanner G A,Keel M,Steckholzer U,et al.Rela tionship between procalcitonin plasma levels and severity of injury,sepsis,o rgan failure,and mortality in injured patients[J].Crit Care Med,2000,28(4 ):950-957.
  • 5Delevaux I,Andre M,Colobier M,et al.Can procalcitionin measuremen t help in differentiating between bacterial infection and other kinds of inflamm atory proces-ses[J].Ann Rheum Dis,2003,62(4):337-340.
  • 6Oliver S,Hartmut H,Michael M,et al.Discrimination of sepsis and systemicinflammatory response Syndrome by determination of circulating plasma co ncentrations of procalcitonin,protein complement 3a,and interlenkin-6 [J].Crit Care Med,2000,28(8):2793-2798.
  • 7Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med, 2003,31 : 1250-1256.
  • 8Hatherill M, Tibby SM, Turner C, et al. Procalcitonin and cytokine levels:relationship to organ failure and mortality in pediatric septic shock. Crit Care Med,2000,28:2591-2594.
  • 9Tang BM, Eslick GD, Craig JC, et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients:systematic review and meta-analysis. Lancet Infect Dis, 2007,7 : 210-217.
  • 10Manana P, Nedelnlkov,4 K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res, 2000,49 Suppl 1 : $57-61.

共引文献328

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部